Japan stands firm over pricing system despite US pressure
This article was originally published in Clinica
Executive Summary
Efforts by industry in the US over the past few years to push Japan into improving its by-function pricing system for medical devices have made little impact. This comes as a great disappointment to US industry, which has repeatedly called for Japan to expand the system's functional categories to allow the recognition of new technology in medical devices - in particular pacemakers, PTCA catheters and orthopaedic implants (see Clinica No 881, p 7).